Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancers|March 6, 2021
Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical AspectsFutoshi Okada, Runa Izutsu, Keisuke Goto, et al.
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|February 26, 2025
Cancer prevention: past challenges and future directionsHeeKyung Seong, Runa Izutsu, Mitsuhiko Osaki, et al.
Pathology, Research and Practice|July 17, 2022
Liver Metastasis Formation Is Defined by AMIGO2 Expression via Adhesion to Hepatic Endothelial Cells in Human Gastric and Colorectal Cancer CellsRuna Izutsu, Mitsuhiko Osaki, Jumond P Jehung, et al.
BMC Cancer|March 17, 2022
The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patientsKeisuke Goto, Masaki Morimoto, Mitsuhiko Osaki, et al.
Cancer Gene Therapy|October 8, 2024
AMIGO2 enhances the invasive potential of colorectal cancer by inducing EMTRuna Izutsu, Mitsuhiko Osaki, HeeKyung Seong, et al.
Scientific Reports|January 18, 2022
AMIGO2 contained in cancer cell-derived extracellular vesicles enhances the adhesion of liver endothelial cells to cancer cellsRuna Izutsu, Mitsuhiko Osaki, Hideyuki Nemoto, et al.
International Journal of Clinical Oncology|May 29, 2024
AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cellsYuki Iida, Mitsuhiko Osaki, Shinya Sato, et al.
Scientific Reports|November 15, 2024
Prevention of liver metastasis via the pharmacological suppression of AMIGO2 expression in tumor cellsHeeKyung Seong, Yusuke Kanda, Runa Izutsu, et al.
Molecular and Clinical Oncology|June 16, 2023
AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate riskYuki Iida, Mitsuhiko Osaki, Shinya Sato, et al.
Pageof 2